177 related articles for article (PubMed ID: 8548952)
1. Chronic myeloid leukaemia following 131I treatment for thyroid carcinoma: a report of two cases and review of the literature.
Shimon I; Kneller A; Olchovsky D
Clin Endocrinol (Oxf); 1995 Nov; 43(5):651-4. PubMed ID: 8548952
[TBL] [Abstract][Full Text] [Related]
2. Chronic myeloid leukemia after treatment with 131 for thyroid carcinoma.
Wang KL; Lin LY; Chen PM; Lin HD
J Chin Med Assoc; 2005 May; 68(5):230-3. PubMed ID: 15909729
[TBL] [Abstract][Full Text] [Related]
3. Chronic myelogenous leukemia after treatment with 131I for thyroid carcinoma. Report of a case and review of the literature.
Walgraeve D; Verhoef G; Stul M; Cassiman JJ; Mecucci C; Van den Berghe H; Boogaerts M
Cancer Genet Cytogenet; 1991 Sep; 55(2):217-24. PubMed ID: 1933823
[TBL] [Abstract][Full Text] [Related]
4. Chronic Myeloid Leukemia following Exposure to Radioactive Iodine (I131): A Systematic Review.
Ali Hailan YM; Al-Dubai HN; Yassin MA
Oncology; 2023; 101(6):362-368. PubMed ID: 37231874
[TBL] [Abstract][Full Text] [Related]
5. Chronic myeloid leukemia in a man with papillary carcinoma of the thyroid treated with radioactive iodine.
Pavithran K; Doval DC
Am J Clin Oncol; 2005 Apr; 28(2):216. PubMed ID: 15803020
[TBL] [Abstract][Full Text] [Related]
6. Leukemia after 131I treatment of thyroid cancer--comments on the article 'Second cancer following chemotherapy and radiotherapy--an epidemiological perspective' by J. Kaldor.
Advani SH; Hege UP
Acta Oncol; 1992; 31(1):65. PubMed ID: 1586507
[No Abstract] [Full Text] [Related]
7. Acute myeloid leukemia after iodine-131 treatment for thyroid disorders.
Laurenti L; Salutari P; Sica S; Piccirillo N; Zini G; Zollino M; Leone G
Ann Hematol; 1998 Jun; 76(6):271-2. PubMed ID: 9692815
[TBL] [Abstract][Full Text] [Related]
8. Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I.
Hilditch TE; Dempsey MF; Bolster AA; McMenemin RM; Reed NS
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):783-8. PubMed ID: 12029552
[TBL] [Abstract][Full Text] [Related]
9. Acute leukemias after treatment with radioiodine for thyroid cancer.
Roldán Schilling V; Fernández Abellán P; Domínguez Escribano JR; Rivas González C; Mut Barberá E; Calatayud Cendra R
Haematologica; 1998 Aug; 83(8):767-8. PubMed ID: 9793274
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the efficacy of iodine-131 for thyroid ablation.
Comtois R; Thériault C; Del Vecchio P
J Nucl Med; 1993 Nov; 34(11):1927-30. PubMed ID: 8229236
[TBL] [Abstract][Full Text] [Related]
11. Preleukemia following large dose radioiodide therapy for metastatic thyroid carcinoma.
Yoosufani Z; Slavin JD; Hellman RM; Sethi SS; Spencer RP
J Nucl Med; 1987 Aug; 28(8):1348-50. PubMed ID: 3612295
[TBL] [Abstract][Full Text] [Related]
12. Leukemia after a small dose of radioiodine for metastatic thyroid cancer.
Bitton R; Sachmechi I; Benegalrao Y; Schneider BS
J Clin Endocrinol Metab; 1993 Nov; 77(5):1423-6. PubMed ID: 8077344
[TBL] [Abstract][Full Text] [Related]
13. Decreased uptake of therapeutic doses of iodine-131 after 185-MBq iodine-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma.
Leger FA; Izembart M; Dagousset F; Barritault L; Baillet G; Chevalier A; Clerc J
Eur J Nucl Med; 1998 Mar; 25(3):242-6. PubMed ID: 9580856
[TBL] [Abstract][Full Text] [Related]
14. Radiation Dose-rate Reduction Pattern in Well-differentiated Thyroid Cancer Treated with I-131.
Khan SA; Khan MS; Arif M; Durr-e-Sabih ; Rahim MK; Ahmad I
J Coll Physicians Surg Pak; 2015 Jul; 25(7):510-3. PubMed ID: 26208555
[TBL] [Abstract][Full Text] [Related]
15. Radioactive iodine lobe ablation as an alternative to completion thyroidectomy for follicular carcinoma of the thyroid.
Randolph GW; Daniels GH
Thyroid; 2002 Nov; 12(11):989-96. PubMed ID: 12490076
[TBL] [Abstract][Full Text] [Related]
16. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
Mazzaferri EL; Jhiang SM
Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
[TBL] [Abstract][Full Text] [Related]
17. 131I therapeutic efficacy is not influenced by stunning after diagnostic whole-body scanning.
Dam HQ; Kim SM; Lin HC; Intenzo CM
Radiology; 2004 Aug; 232(2):527-33. PubMed ID: 15286323
[TBL] [Abstract][Full Text] [Related]
18. Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131.
Park HM; Perkins OW; Edmondson JW; Schnute RB; Manatunga A
Thyroid; 1994; 4(1):49-54. PubMed ID: 8054861
[TBL] [Abstract][Full Text] [Related]
19. Lithium as an adjuvant in the postoperative ablation of remnant tissue in low-risk thyroid carcinoma.
Yamazaki CA; Padovani RP; Biscolla RP; Ikejiri ES; Marchetti RR; Castiglioni ML; Matsumura LK; Maciel RM; Furlanetto RP
Thyroid; 2012 Oct; 22(10):1002-6. PubMed ID: 22953991
[TBL] [Abstract][Full Text] [Related]
20. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma.
Menzel C; Grünwald F; Schomburg A; Palmedo H; Bender H; Späth G; Biersack HJ
J Nucl Med; 1996 Sep; 37(9):1496-503. PubMed ID: 8790201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
